InnovHeart rallies $55m Series C
InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing.
InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination